Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital

Transoral robotic surgery: a 4-year learning experience in a single Danish Cancer Centre

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Nordic results of cochlear implantation in adults: speech perception and patient reported outcomes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Development of depression in patients with oral cavity cancer: a systematic review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Association between head and neck cancer and sexually transmitted diseases: a Danish nationwide, case-control study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. TORS Base-of-Tongue Mucosectomy in Human Papilloma Virus-Negative Carcinoma of Unknown Primary

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Penetrating Orbital Sphenoid Sinus Trauma with a Wooden Stick: A Challenging Case Report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Background: The main indication for transoral robotic surgery (TORS) has been the primary treatment of oropharyngeal squamous cell carcinoma (OPSCC). In the western world this is highly relevant due to the increasing incidence of human papillomavirus (HPV)-positive OPSCC. In Denmark, TORS was implemented in 2013 for use in the protocolled primary treatment of OPSCC.Aims/objectives: To perform a year-by-year comparative analysis of indications for TORS, hospitalization and complication rates to identify optimal future indications for TORS.Methods and materials: This is a retrospective single-centre case review from 2013-2017. Data were collected from patient files through electronic health care systems.Results: Since 2013, there has been a change of indications from performing benign and salvage surgery to mainly primary treatment of OPSCC and diagnostic use in patients with cancer of unknown primary (CUP). The overall complication rates have reduced considerably over time.Conclusions and significance: Lower complication rates may be explained by improved surgical experience, through better patient selection and changes in indications for TORS. Future applications of TORS will be in the management of CUP and as part of a Danish national randomized clinical trial aiming to compare long-term functional outcomes after treatment of early-stage OPSCC with TORS versus radiation treatment.

TidsskriftActa Oto-Laryngologica
Udgave nummer2
Sider (fra-til)157-162
Antal sider6
StatusUdgivet - feb. 2020

ID: 59839663